Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes.
Visfatin has been proposed as an insulin-mimicking adipocytokine, predominantly secreted from adipose tissue and correlated with obesity. However, recent studies suggest visfatin may act as a proinflammatory cytokine. Our studies sought to determine the significance of this adipocytokine and its pot...
Main Authors: | Kirsty C McGee, Alison L Harte, Nancy F da Silva, Nasser Al-Daghri, Steven J Creely, Christine M Kusminski, Gyanendra Tripathi, Paul L Levick, Manish Khanolkar, Marc Evans, Madhu V Chittari, Vinod Patel, Sudhesh Kumar, Philip G McTernan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3111427?pdf=render |
Similar Items
-
Rosiglitazone remodels the lipid droplet and britens human visceral and subcutaneous adipocytes ex vivo[S]
by: Mi-Jeong Lee, et al.
Published: (2019-04-01) -
The regulation of visfatin on genes related to lipidmetabolism in porcine adipocytes
by: Su-Jiun Deng, et al.
Published: (2008) -
The effects of the adipocyte-secreted proteins resistin and visfatin on the pancreatic beta-cell
by: Onyango, David J.
Published: (2009) -
Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in south-Asians
by: Barnett A H, et al.
Published: (2006-05-01) -
Conservation Potential of a Semi-Forested Agricultural Landscape: Diversity and SpatialDistribution of Birds within a Large-Scale Ugandan Coffee Farm
by: McTernan, Michael F.
Published: (2019)